[Salem, Massachusetts – November 7, 2018] CDX Analytics is thrilled to have received our Notice to Commence Operations today from the Cannabis Control Commission. This letter from the commission confirms that CDX has complied with all provisions of obtaining and maintaining a license to test cannabis products for the Recreational Marijuana market in the state.
“The Massachusetts Adult Use Program must give consumers confidence in the safety and labeling of the products they are buying. This step forward is the culmination of the hard work put in by our team and the diligence of the Commission and its staff. We will be providing written notice to the CCC that we intend to commence operations immediately.”
“We look forward to serving consumers in this fashion as the premier independent testing laboratory in the Commonwealth.” – Dr. Brian Strasnick, CEO/President
CDX Analytics is a premiere cannabis testing laboratory servicing both the Medical and Recreational Marijuana markets. The lab has invested in state-of-the-art instrumentation to ensure state compliance and push the envelope in product optimization.
If you would like more information about this topic or about the services provided by CDX Analytics, please call Eamon Travers at 781-469-5770, or email email@example.com.